Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sensors (Basel) ; 24(9)2024 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-38733011

RESUMO

Demand is strong for sensitive, reliable, and cost-effective diagnostic tools for cancer detection. Accordingly, bead-based biosensors have emerged in recent years as promising diagnostic platforms based on wide-ranging cancer biomarkers owing to the versatility, high sensitivity, and flexibility to perform the multiplexing of beads. This comprehensive review highlights recent trends and innovations in the development of bead-based biosensors for cancer-biomarker detection. We introduce various types of bead-based biosensors such as optical, electrochemical, and magnetic biosensors, along with their respective advantages and limitations. Moreover, the review summarizes the latest advancements, including fabrication techniques, signal-amplification strategies, and integration with microfluidics and nanotechnology. Additionally, the challenges and future perspectives in the field of bead-based biosensors for cancer-biomarker detection are discussed. Understanding these innovations in bead-based biosensors can greatly contribute to improvements in cancer diagnostics, thereby facilitating early detection and personalized treatments.


Assuntos
Biomarcadores Tumorais , Técnicas Biossensoriais , Neoplasias , Técnicas Biossensoriais/métodos , Técnicas Biossensoriais/instrumentação , Humanos , Neoplasias/diagnóstico , Biomarcadores Tumorais/análise , Técnicas Eletroquímicas/métodos , Nanotecnologia/tendências , Nanotecnologia/métodos , Nanotecnologia/instrumentação , Microfluídica/métodos , Microfluídica/instrumentação , Microfluídica/tendências
2.
Medicine (Baltimore) ; 101(34): e30217, 2022 Aug 26.
Artigo em Inglês | MEDLINE | ID: mdl-36042603

RESUMO

BACKGROUND: Urology authors are required to evaluate research achievements (RAs) in the field of bladder cancer (BC). However, no such bibliometric indices were appropriately applied to quantify the contributions to BC in research. In this study, we examined 3 questions: whether RAs in China are higher than those in the United States, how the Sankey-based temporal bar graph (STBG) may be applied to the analysis of the trend of article citations in the BC field, and what subthemes were reflected in China's and the United States' proportional counts in BC articles. METHODS: Using the PubMed search engine to download data, we conducted citation analyses of BC articles authored by urology scholars since 2012. A total of 9885 articles were collected and analyzed using the relative citations ratios (RCRs) and the STBG. The 3 research goals were verified using the RCRs, the STBG, and medical subject headings (MesH terms). The choropleth map and the forest plot were used to 1 highlight the geographical distributions of publications and RCRs for countries/regions and 2 compare the differences in themes (denoted by major MeSH terms on proportional counts using social network analysis to cluster topics) between China and the United States. RESULTS: There was a significant rise over the years in RCRs within the 9885 BC articles. We found that the RCRs in China were substantially higher than those in the United States since 2017, the STBG successfully explored the RCR trend of BC articles and was easier and simpler than the traditional line charts, area plots, and TBGs, and the subtheme of genetics in China has a significantly higher proportion of articles than the United States. The most productive and influential countries/regions (denoted by RCRs) were {Japan, Germany, and Italy} and {Japan, Germany, New York}, respectively, when the US states and provinces/metropolitan cities/areas in China were separately compared to other countries/regions. CONCLUSIONS: With an overall increase in publications and RCRs on BC articles, research contributions assessed by the RCRs and visualized by the STBGs are suggested for use in future bibliographical studies.


Assuntos
Neoplasias da Bexiga Urinária , Bibliometria , China/epidemiologia , Humanos , New York , PubMed , Estados Unidos
3.
Int J Mol Sci ; 21(12)2020 Jun 19.
Artigo em Inglês | MEDLINE | ID: mdl-32575412

RESUMO

Dysregulation of fatty acid oxidation and accumulation of fatty acids can cause kidney injury. Nifedipine modulates lipogenesis-related transcriptional factor SREBP-1/2 in proximal tubular cells by inhibiting the Adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway in vitro. However, the mechanisms by which nifedipine (NF) modulates lipotoxicity in vivo are unclear. Here, we examined the effect of NF in a doxorubicin (DR)-induced kidney injury rat model. Twenty-four Sprague-Dawley rats were divided into control, DR, DR+NF, and high-fat diet (HFD) groups. The DR, DR+NF, and HFD groups showed hypertension and proteinuria. Western blotting and immunohistochemical analysis showed that NF significantly induced TNF-α, CD36, SREBP-1/2, and acetyl-CoA carboxylase expression and renal fibrosis, and reduced fatty acid synthase and AMPK compared to other groups (p < 0.05). Additionally, 18 patients with chronic kidney disease (CKD) who received renal transplants were enrolled to examine their graft fibrosis and lipid contents via transient elastography. Low-density lipoprotein levels in patients with CKD strongly correlated with lipid contents and fibrosis in grafted kidneys (p < 0.05). Thus, NF may initiate lipogenesis through the SREBP-1/2/AMPK pathway and lipid uptake by CD36 upregulation and aggravate renal fibrosis in vivo. Higher low-density lipoprotein levels may correlate with renal fibrosis and lipid accumulation in grafted kidneys of patients with CKD.


Assuntos
Antígenos CD36/metabolismo , Doxorrubicina/efeitos adversos , Receptor Celular 1 do Vírus da Hepatite A/metabolismo , Lipogênese/efeitos dos fármacos , Nifedipino/efeitos adversos , Insuficiência Renal Crônica/terapia , Proteínas de Ligação a Elemento Regulador de Esterol/metabolismo , Animais , Dieta Hiperlipídica , Modelos Animais de Doenças , Feminino , Regulação da Expressão Gênica/efeitos dos fármacos , Humanos , Transplante de Rim , Lipoproteínas LDL/metabolismo , Masculino , Pessoa de Meia-Idade , Ratos , Ratos Sprague-Dawley , Insuficiência Renal Crônica/induzido quimicamente , Insuficiência Renal Crônica/metabolismo , Regulação para Cima
4.
Int Urol Nephrol ; 51(8): 1335-1342, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-31129781

RESUMO

PURPOSE: In recent years, second-look transurethral resection of bladder tumors (TURBT) has been recommended for patients with stage T1 bladder cancer after the initial TURBT for restaging and deciding the subsequent treatment. However, we believe that second-look TURBT has therapeutic benefits, such as low incidence of recurrence and progression. Therefore, we compare the differences in long-term outcome between patients who did and did not accept second-look TURBT for stage T1 bladder cancer. METHODS: We assessed 504 patients diagnosed with urothelial carcinoma who underwent initial TURBT between January 2012 and December 2016 at a single medical center; of these patients, 177 were diagnosed with T1 bladder cancer during the initial TURBT, and we excluded no muscle from the specimen in the initial TURBT. The patients were categorized into groups 1 and 2 based on the acceptance of second-look TURBT, which was performed within 4-14 weeks after the initial TURBT. Group 1 underwent second-look TURBT, but group 2 did not. Both groups were followed-up for recurrence-free survival (RFS) and progression-free survival (PFS), and the risk factors for recurrence and progression were analyzed. RESULTS: In total, 93 (52.5%) patients in group 1 underwent second-look TURBT, and 84 (47.5%) in group 2 did not. The 2-year RFS rates were 74.6% and 60.0% and the PFS rates were 91.2% and 87.5% in groups 1 and 2, respectively. CONCLUSION: This study demonstrated higher recurrence-free and progression-free survival rates for patients who underwent second-look TURBT. This result emphasizes the importance of second-look TURBT in stage T1 bladder cancer not only for restaging but also for therapeutic benefit.


Assuntos
Carcinoma de Células de Transição/cirurgia , Cistectomia/métodos , Reoperação , Neoplasias da Bexiga Urinária/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma de Células de Transição/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Estudos Retrospectivos , Uretra , Neoplasias da Bexiga Urinária/patologia
5.
J Cell Physiol ; 232(9): 2538-2549, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27723141

RESUMO

DC-STAMP is a multi-pass transmembrane protein essential for cell-cell fusion between osteoclast precursors during osteoclast (OC) development. DC-STAMP-/- mice have mild osteopetrosis and form mononuclear cells with limited resorption capacity. The identification of an Immunoreceptor Tyrosine-based Inhibitory Motif (ITIM) on the cytoplasmic tail of DC-STAMP suggested a potential signaling function. The absence of a known DC-STAMP ligand, however, has hindered the elucidation of downstream signaling pathways. To address this problem, we engineered a light-activatable DC-STAMP chimeric molecule in which light exposure mimics ligand engagement that can be traced by downstream Ca2+ signaling. Deletion of the cytoplasmic ITIM resulted in a significant elevation in the amplitude and duration of intracellular Ca2+ flux. Decreased NFATc1 expression in DC-STAMP-/- cells was restored by DC-STAMP over-expression. Multiple biological phenotypes including cell-cell fusion, bone erosion, cell mobility, DC-STAMP cell surface distribution, and NFATc1 nuclear translocation were altered by deletion of the ITIM and adjacent amino acids. In contrast, mutations on each of the tyrosine residues surrounding the ITIM showed no effect on DC-STAMP function. Collectively, our results suggest that the ITIM on DC-STAMP is a functional motif that regulates osteoclast differentiation through the NFATc1/Ca2+ axis. J. Cell. Physiol. 232: 2538-2549, 2017. © 2016 Wiley Periodicals, Inc.


Assuntos
Células da Medula Óssea/metabolismo , Sinalização do Cálcio , Diferenciação Celular , Proteínas de Membrana/metabolismo , Fatores de Transcrição NFATC/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Osteoclastos/metabolismo , Osteogênese , Osteopetrose/metabolismo , Transporte Ativo do Núcleo Celular , Animais , Células da Medula Óssea/patologia , Fusão Celular , Movimento Celular , Forma Celular , Células Cultivadas , Predisposição Genética para Doença , Proteínas de Membrana/deficiência , Proteínas de Membrana/genética , Camundongos Knockout , Mutação , Proteínas do Tecido Nervoso/deficiência , Proteínas do Tecido Nervoso/genética , Osteoclastos/patologia , Osteólise/metabolismo , Osteólise/patologia , Osteólise/fisiopatologia , Osteopetrose/genética , Osteopetrose/patologia , Osteopetrose/fisiopatologia , Fenótipo , Domínios e Motivos de Interação entre Proteínas , Fatores de Tempo , Transfecção
6.
Biosens Bioelectron ; 89(Pt 2): 701-709, 2017 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-27865104

RESUMO

Early diagnosis of diabetic retinopathy (DR) is vital but challenging. DR is a common complication and a major cause of vision loss in patients with diabetes mellitus. Without appropriate medical intervention, visual impairment may become a great burden to our healthcare system. In clinical practice, the current diagnostic methods, such as fluorescence angiography and optical coherence tomography, remain constrained by non-quantitative examinations and individual ophthalmologists' experiences. Late diagnosis often prevents early treatment. To address the constraints on current diagnostics, this study developed an optoelectrokinetic bead-based immunosensing technique for detecting lipocalin 1 (LCN1), a DR biomarker. The concentration level of LCN1 in the tears of DR patients increases with DR severity. The immunoassay was dependent on the formation of sandwiched immunocomplexes on the particles. A secondary antibody labeled with dyes/quantum dots (QDs) was used to visualize the presence of the target antigens. Rapid electrokinetic patterning (REP), an optoelectrokinetic technique, was used to dynamically enhance the fluorescent signal by concentrating the modified particles. The limit of detection (LOD) of the technique could reach 110pg/mL. Only 1.5µL of a sample fluid was required for the measurement. Our results showed that highly sensitive and improved LOD is subjected to particle stacking, small particle size, and compact cluster. By labeling different particle sizes with dyes/QDs for LCN1 and TNF-α, we successfully used REP to detect the two DR biomarkers on the same platform. The development of an optoelectrokinetic bead-based immunosensing technique can provide new insights into diagnosing other low-abundance diseases in the future.


Assuntos
Técnicas Biossensoriais/instrumentação , Retinopatia Diabética/diagnóstico , Imunoensaio/instrumentação , Lipocalina 1/análise , Lágrimas/química , Fator de Necrose Tumoral alfa/análise , Animais , Anticorpos Imobilizados/química , Biomarcadores/análise , Técnicas Biossensoriais/métodos , Corantes/química , Campos Eletromagnéticos , Desenho de Equipamento , Humanos , Imunoensaio/métodos , Dispositivos Ópticos , Pontos Quânticos/química
7.
J Formos Med Assoc ; 110(11): 695-700, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22118313

RESUMO

BACKGROUND/PURPOSE: A possible means of decreasing prostate cancer mortality is through improved early detection. We attempted to create an equation to predict the likelihood of having prostate cancer. METHODS: Between January 2005 and May 2008, patients who received prostate biopsies were retrospective evaluated. The relationship between the possibility of prostate cancer and the following variables were evaluated: age; serum prostate specific antigen (PSA) level, prostate volume, numbers of prostatic biopsies, digital rectal examination (DRE) findings, and the presence of hypoechoic nodule under transrectal ultrasonography. RESULTS: A multivariate regression model was created to predict the possibility of having prostate cancer, and a receiver-operating characteristic (ROC) curve was drawn based on the predictive scoring equation. Using a predictive equation, P=1/(1-e(-x)), where X=-4.88,+1.11 (if DRE positive),+0.75 (if hypoechoic nodule of prostate present),+1.27 (when 7

Assuntos
Neoplasias da Próstata/etiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Exame Retal Digital , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Antígeno Prostático Específico/sangue , Neoplasias da Próstata/diagnóstico , Curva ROC , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA